Use of TLR agonists and/or type 1 interferons to alleviate toxicity of TNF-R agonist therapeutic regimens

Details for Australian Patent Application No. 2008265911 (hide)

Owner Immurx, Inc.

Inventors Ahonen, Cory; Kedl, Ross; Noelle, Randolph

Agent Watermark

Pub. Number AU-A-2008265911

PCT Pub. Number WO2008/157473

Priority 60/944,288 15.06.07 US

Filing date 16 June 2008

Wipo publication date 24 December 2008

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2008/157473 Priority application(s): WO2008/157473

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008265912-Method and apparatus for geobaric analysis

2008265902-High temperature roll